Xiangyang Yao

1.3k total citations · 1 hit paper
24 papers, 958 citations indexed

About

Xiangyang Yao is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine. According to data from OpenAlex, Xiangyang Yao has authored 24 papers receiving a total of 958 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Pathology and Forensic Medicine. Recurrent topics in Xiangyang Yao's work include RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Xiangyang Yao is often cited by papers focused on RNA modifications and cancer (4 papers), RNA Research and Splicing (4 papers) and Bioactive Compounds and Antitumor Agents (2 papers). Xiangyang Yao collaborates with scholars based in China, United States and India. Xiangyang Yao's co-authors include Jing Luo, Fengjing Guo, Jing Xiong, Kai Sun, Guilan Li, Hui Xu, Haoran Liu, Hua Xu, Zhimin Yin and Chen Duan and has published in prestigious journals such as Nucleic Acids Research, SHILAP Revista de lepidopterología and Journal of Virology.

In The Last Decade

Xiangyang Yao

22 papers receiving 942 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review

2020 447 citations Kai Sun, Jing Luo et al. Osteoarthritis and Cartilage profile →

Peers

Countries citing papers authored by Xiangyang Yao

Since Specialization

Citations

This map shows the geographic impact of Xiangyang Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiangyang Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiangyang Yao more than expected).

Fields of papers citing papers by Xiangyang Yao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiangyang Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiangyang Yao. The network helps show where Xiangyang Yao may publish in the future.

Co-authorship network of co-authors of Xiangyang Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Xiangyang Yao. A scholar is included among the top collaborators of Xiangyang Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiangyang Yao. Xiangyang Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Sirtuin1 Suppresses Calcium Oxalate Nephropathy via Inhibition of Renal Proximal Tubular Cell Ferroptosis Through PGC‐1α‐mediated Transcriptional Coactivation 2024 ·Advanced Science ·(unknown), Bo Li, Haoran Liu, Yangjun Zhang, Xiangyang Yao, (unknown), Xiaoliang Wu, (unknown), (unknown), Zhenzhen Xu, (unknown), Zhiquan Hu, Yan Gong, (unknown)	9
2	The role of BUD31 in clear cell renal cell carcinoma: prognostic significance, alternative splicing, and tumor immune environment 2024 ·Clinical and Experimental Medicine ·Xiaoliang Wu, Ruixin Fan, Yangjun Zhang, (unknown), Xiangyang Yao, Kai Liu, Dongxu Lin, Zhong Chen	1
3	CircSP3 encodes SP3-461aa to promote ccRCC progression via stabilizing MYH9 and activating the PI3K-Akt signaling pathway 2024 ·Journal of Cancer ·Xiaoliang Wu, Guoliang Sun, Ruixin Fan, (unknown), (unknown), (unknown), (unknown), Xiangyang Yao, Bo Li, Ke Chen, Yangjun Zhang, Zhong Chen	1
4	OncoSplicing 3.0: an updated database for identifying RBPs regulating alternative splicing events in cancers 2024 ·Nucleic Acids Research ·Yangjun Zhang, (unknown), Zhenzhen Xu, Bo Li, Xiaoliang Wu, Ruixin Fan, Xiangyang Yao, (unknown), Chen Duan, Yan Gong, Ke Chen, Jin Zeng, Lu Li, Hua Xu	0
5	Identification of alternative splicing associated with clinical features: from pan-cancers to genitourinary tumors 2023 ·Frontiers in Oncology ·Chen Duan, Yangjun Zhang, Lu Li, (unknown), Xiangyang Yao, Xiaoliang Wu, Bo Li, (unknown), (unknown), Haoran Liu, Jin Zeng, Sheng Li, Yan Gong, Zhiquan Hu, Hua Xu	2
6	Comprehensive characteristics of pathological subtypes in testicular germ cell tumor: Gene expression, mutation and alternative splicing 2023 ·Frontiers in Immunology ·Xiangyang Yao, Hui Zhou, Chen Duan, Xiaoliang Wu, Bo Li, Haoran Liu, Yangjun Zhang	8
7	Metabolic changes in kidney stone disease 2023 ·Frontiers in Immunology ·Zhenzhen Xu, Xiangyang Yao, Chen Duan, Haoran Liu, Hua Xu	33
8	Clinical features and effectiveness of Chinese medicine in patients with COVID-19 from overseas: A retrospective study in Xiamen, China 2022 ·Frontiers in Public Health ·Yuxuan Huang, (unknown), (unknown), (unknown), Xiangyang Yao, (unknown), Xianzhong Huang, (unknown), (unknown), (unknown), Manman Zhang, Li‐Tao Yi, Xueqin Chen	2
9	XIST Inhibition Attenuates Calcium Oxalate Nephrocalcinosis‐Induced Renal Inflammation and Oxidative Injury via the miR‐223/NLRP3 Pathway 2021 ·Oxidative Medicine and Cellular Longevity ·Peng Lv, Haoran Liu, Tao Ye, Xiaoqi Yang, Chen Duan, Xiangyang Yao, Bo Li, Kun Tang, Zhiqiang Chen, Jianhe Liu, Yaoliang Deng, Tao Wang, Jinchun Xing, Chang Yin Liang, Hua Xu, Zhangqun Ye	32
10	The Impact of Metformin Use with Survival Outcomes in Urologic Cancers: A Systematic Review and Meta‐Analysis 2021 ·BioMed Research International ·Xiangyang Yao, Haoran Liu, Hua Xu	7
11	XIST Promote Calcium Oxalate Nephrocalcinosis Induced Renal Inflammatory and Oxidative Injury Via miR-223-NLRP3 Pathway 2021 ·SSRN Electronic Journal ·Peng Lv, Haoran Liu, Tao Ye, Xiaoqi Yang, Chen Duan, Xiangyang Yao, Bo Li, Kun Tang, Zhiqiang Chen, Tao Wang, Yaoliang Deng, Guohua Zeng, Jianhe Liu, Jinchun Xing, Zhangqun Ye, Hua Xu	0
12	The PI3K/AKT/mTOR signaling pathway in osteoarthritis: a narrative review breakdown → 2020 ·Osteoarthritis and Cartilage ·Kai Sun, Jing Luo, (unknown), Xiangyang Yao, Jing Xiong, Fengjing Guo	447
13	Development of an ORF45-Derived Peptide To Inhibit the Sustained RSK Activation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus 2019 ·Journal of Virology ·Xiaojuan Li, Lu Huang, Yunjun Xiao, Xiangyang Yao, (unknown), Fanxiu Zhu, Ersheng Kuang	12
14	Taraxerol Induces Cell Apoptosis through A Mitochondria-Mediated Pathway in HeLa Cells. 2017 ·SHILAP Revista de lepidopterología ·Xiangyang Yao, Binyu Lu, (unknown), (unknown), Dazhong Yan, Hui Xu	15
15	Solanesol induces the expression of heme oxygenase-1 via p38 and Akt and suppresses the production of proinflammatory cytokines in RAW264.7 cells 2016 ·Food & Function ·Xiangyang Yao, Binyu Lu, (unknown), (unknown), Dazhong Yan, Yanli Wu, (unknown), Hui Xu	21
16	Solanesol protects human hepatic L02 cells from ethanol-induced oxidative injury via upregulation of HO-1 and Hsp70 2015 ·Toxicology in Vitro ·Xiangyang Yao, (unknown), Dazhong Yan, Guilan Li, (unknown), Hui Xu	31
17	Taraxerol inhibits LPS-induced inflammatory responses through suppression of TAK1 and Akt activation 2013 ·International Immunopharmacology ·Xiangyang Yao, Guilan Li, (unknown), Hui Xu, (unknown)	42
18	Arctigenin promotes degradation of inducible nitric oxide synthase through CHIP-associated proteasome pathway and suppresses its enzyme activity 2012 ·International Immunopharmacology ·Xiangyang Yao, Guilan Li, (unknown), Hui Xu, Zhimin Yin	20
19	l-Theanine prevents alcoholic liver injury through enhancing the antioxidant capability of hepatocytes 2011 ·Food and Chemical Toxicology ·Guilan Li, Yin Ye, Jingjing Kang, Xiangyang Yao, Yizhou Zhang, Wei Jiang, Min Gao, (unknown), Yinqiang Xin, Qi Wang, Zhimin Yin, Lan Luo	93
20	The component of green tea, L-theanine protects human hepatic L02 cells from hydrogen peroxide-induced apoptosis 2011 ·European Food Research and Technology ·Guilan Li, Jingjing Kang, Xiangyang Yao, Yinqiang Xin, Qi Wang, Ye Yin, Lan Luo, Zhimin Yin	13

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact